LETAIRIS Patient Information (required) Provider Information (required)
Letairis (Ambrisentan Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Letairis: Package Insert / Prescribing Information - Drugs.com
Ambrisentan (Letairis): Basics, Side Effects & Reviews
New generic drugs available in 2019 after FDA approval
Page 1 of 6 Clinical Policy: Ambrisentan (Letairis) Reference Number: HIM.PA.SP4 Effective Date: 05/17 Coding Implications Last
Pulmonary arterial hypertension - Updated January 2020
Financial Support | Letairis® (ambrisentan)
Letairis Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Medicare Advantage Medical Benefit Drug Policy
Letairis: Package Insert / Prescribing Information - Drugs.com
Prior Authorization - Pulmonary Arterial Hypertension – Endothelin Receptor Antagonists
Letairis (ambrisentan) 5 mg and 10 mg Tablets.
FDA approves multiple Letairis generics, related REMS programs | Drug Store News
Letairis (Ambrisentan Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Prior Authorization (PA) Form for Letairis (Ambrisentan) Tracleer (Bosentan) Opsumit (Macitentan)
Ambrisentan (Letairis): Basics, Side Effects & Reviews
Ambrisentan (Letairis): Basics, Side Effects & Reviews
Letairis (Ambrisentan Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Ambrisentan (Letairis): Basics, Side Effects & Reviews
Clinical Policy: Ambrisentan (Letairis)
Teva Launches Generic Version of PAH Therapy Letairis in US
